CELLULARORIGINS.COM: Keyword Density Checker

Total words: 1111 | 2-word phrases: 288 | 3-word phrases: 307 | 4-word phrases: 314

PAGE INFO

Title	Try to keep the title under 60 characters (23 characters) Home \| Cellular Origins
Description	Try to keep the meta description between 50 - 160 characters (160 characters) Cellular Origins is building scalable cell therapy automation manufacturing solution. Cellular Origins brings advanced robotics automation to cell therapy f ...
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (48 characters) Enabling patient access to cell therapy at scale

#	Keyword	Frequency	Density
1	44 0 1763 262626	2	0.64%
2	for cell and gene	2	0.64%
3	origins all rights reserved	1	0.32%
4	innovative and ambitious companies	1	0.32%
5	closed configurable robotic cell	1	0.32%
6	configurable robotic cell therapy	1	0.32%
7	robotic cell therapy automation	1	0.32%
8	cell therapy automation platform	1	0.32%
9	therapy automation platform at	1	0.32%
10	supporting the world’s most	1	0.32%
11	society for cell and	1	0.32%
12	the international society for cell	1	0.32%
13	launch of constellation its	1	0.32%
14	cell and gene therapy	1	0.32%
15	and gene therapy isct	1	0.32%
16	gene therapy isct annual	1	0.32%
17	in supporting the world’s	1	0.32%
18	experience in supporting the	1	0.32%
19	years’ experience in supporting	1	0.32%
20	30 years’ experience in	1	0.32%
21	and ambitious companies develop	1	0.32%
22	the launch of constellation	1	0.32%
23	than 30 years’ experience	1	0.32%
24	and spaceefficient manufacture of	1	0.32%
25	a ttp company focused	1	0.32%
26	ttp company focused on	1	0.32%
27	company focused on enabling	1	0.32%
28	focused on enabling scalable	1	0.32%
29	new tools and technologies	1	0.32%
30	develop new tools and	1	0.32%
31	costeffective and spaceefficient manufacture	1	0.32%
32	spaceefficient manufacture of cell	1	0.32%
33	announced the launch of	1	0.32%
34	manufacture of cell and	1	0.32%
35	operation of your process	1	0.32%
36	cell and gene therapies	1	0.32%
37	companies develop new tools	1	0.32%
38	ambitious companies develop new	1	0.32%
39	therapies cgts has announced	1	0.32%
40	cgts has announced the	1	0.32%